Enanta Pharmaceuticals, Inc. (ENTA) RSVHR Study Results Call
PresentationGood morning, and welcome to Enanta Pharmaceuticals Conference Call. [Operator Instructions] Please be advised that this call is being recorded. I would now like to turn the call over to Jennifer Viera, Head of Investor Relations. Please go ahead.Jennifer VieraExecutive Director of Investor Relations & Corporate Communications Thank you, operator, and thanks to everyone for joining us this morning. The news release announcing the top line results of our RSVHR study became available earlier this ...